Table 1: R44K^S against MRSA (SA 180-F Strain) shows ↓ (0.1 mg/mL).
- Measure
- qualitative
- Value
- ↓ (0.1 mg/mL)
- Target
- Staphylococcus aureus
- Assay
- Not reported by source
International Journal of Molecular Sciences · 2025
Sequence evidence
RKKRRQRRRGGGGVVVHINGGKFGGGGSRQIKIWFQNRRMKWKK
RKKRRQRRRGGGGVVVHINGGKFGGGGSRQIKIWFQNRRMKWKK
Experimental observations
Table 1: R44K^S against MRSA (SA 180-F Strain) shows ↓ (0.1 mg/mL).
Table 1: R44K^S against S. aureus (129B Strain) shows ↓ (10 mg/mL).
Table 1: R44K^S against E. coli (MG1655 Strain) shows ↓ (0.1 mg/mL).
Table 1: R44K^S against P. aeruginosa (2943 Strain) shows ↓ (10 mg/mL).
Table 2: R44K^S at 1 mg/mL against MRSA shows + (inhibition zone).
Table 2: R44K^S at 0.1 mg/mL against MRSA shows − (no inhibition zone).
Table 2: R44K^S at 0.01 mg/mL against MRSA shows − (no inhibition zone).
Table 2: R44K^S at 0.001 mg/mL against MRSA shows − (no inhibition zone).
Table 2: R44K^S at 1 mg/mL against S. aureus 129B shows + (inhibition zone).
Table 2: R44K^S at 0.1 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: R44K^S at 0.01 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: R44K^S at 0.001 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: R44K^S at 1 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: R44K^S at 0.1 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: R44K^S at 0.01 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: R44K^S at 0.001 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: R44K^S at 1 mg/mL against P. aeruginosa 2943 shows + (inhibition zone).
Table 2: R44K^S at 0.1 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 2: R44K^S at 0.01 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 2: R44K^S at 0.001 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 3: R44K^S against MRSA early biofilm after crystal violet staining shows ↓ (1 mg/mL).
Table 3: R44K^S against S. aureus 129B early biofilm after crystal violet staining shows ↑ (reverse effect).
Table 3: R44K^S against E. coli MG1655 early biofilm after crystal violet staining shows ↑ (reverse effect).
Table 3: R44K^S against P. aeruginosa 2943 early biofilm after crystal violet staining shows ↓ (10 mg/mL).
Table 3: R44K^S against MRSA early biofilm after MTT assay shows ↑ (reverse effect).
Table 3: R44K^S against S. aureus 129B early biofilm after MTT assay shows ↑ (reverse effect).
Table 3: R44K^S against E. coli MG1655 early biofilm after MTT assay shows − (no decrease).
Table 3: R44K^S against P. aeruginosa 2943 early biofilm after MTT assay shows − (no decrease).
Table 4: R44K^S against MRSA mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: R44K^S against S. aureus 129B mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: R44K^S against E. coli MG1655 mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: R44K^S against P. aeruginosa 2943 mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: R44K^S against MRSA mature biofilm after MTT assay shows ↓ (0.01 mg/mL).
Table 4: R44K^S against S. aureus 129B mature biofilm after MTT assay shows − (no decrease).
Table 4: R44K^S against E. coli MG1655 mature biofilm after MTT assay shows ↑ (reverse effect).
Table 4: R44K^S against P. aeruginosa 2943 mature biofilm after MTT assay shows ↑ (reverse effect).
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.